These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

511 related items for PubMed ID: 15830829

  • 1. Hemorrhages during escitalopram-venlafaxine-mirtazapine combination treatment of depression.
    Benazzi F.
    Can J Psychiatry; 2005 Mar; 50(3):184. PubMed ID: 15830829
    [No Abstract] [Full Text] [Related]

  • 2. Re: Hemorrhages during escitalopram-venlafaxine-mirtazapine combination treatment of depression.
    Al-Adwani A.
    Can J Psychiatry; 2005 Nov; 50(13):877; author reply 877-8. PubMed ID: 16483124
    [No Abstract] [Full Text] [Related]

  • 3. Safety and tolerability of the new antidepressants.
    Nelson JC.
    J Clin Psychiatry; 1997 Nov; 58 Suppl 6():26-31. PubMed ID: 9227670
    [Abstract] [Full Text] [Related]

  • 4. [Applications and safety of modern antidepressants in patients with liver diseases].
    Dubarek W, Kucia K.
    Wiad Lek; 2007 Nov; 60(1-2):28-33. PubMed ID: 17607965
    [Abstract] [Full Text] [Related]

  • 5. Dual action antidepressants and some important considerations.
    Gupta RK, Tiller JW, Burrows GD.
    Aust N Z J Psychiatry; 2003 Apr; 37(2):190-5. PubMed ID: 12656958
    [Abstract] [Full Text] [Related]

  • 6. The impact of chronic depression on acute and long-term outcomes in a randomized trial comparing selective serotonin reuptake inhibitor monotherapy versus each of 2 different antidepressant medication combinations.
    Sung SC, Haley CL, Wisniewski SR, Fava M, Nierenberg AA, Warden D, Morris DW, Kurian BT, Trivedi MH, Rush AJ, CO-MED Study Team.
    J Clin Psychiatry; 2012 Jul; 73(7):967-76. PubMed ID: 22687487
    [Abstract] [Full Text] [Related]

  • 7. [Combining venlafaxine and mirtazapine for the treatment of major depression with dysthymia--"double depression"].
    Ladeira RB, Cunha FT, Salgado JV, Teixeira AL, Nicolato R.
    Braz J Psychiatry; 2008 Sep; 30(3):299-300. PubMed ID: 18833439
    [No Abstract] [Full Text] [Related]

  • 8. Efficacy of escitalopram in the treatment of major depressive disorder compared with conventional selective serotonin reuptake inhibitors and venlafaxine XR: a meta-analysis.
    Kennedy SH, Andersen HF, Lam RW.
    J Psychiatry Neurosci; 2006 Mar; 31(2):122-31. PubMed ID: 16575428
    [Abstract] [Full Text] [Related]

  • 9. Long-term side effects of newer-generation antidepressants: SSRIS, venlafaxine, nefazodone, bupropion, and mirtazapine.
    Masand PS, Gupta S.
    Ann Clin Psychiatry; 2002 Sep; 14(3):175-82. PubMed ID: 12585567
    [Abstract] [Full Text] [Related]

  • 10. Discontinuation rates for selective serotonin reuptake inhibitors and other second-generation antidepressants in outpatients with major depressive disorder: a systematic review and meta-analysis.
    Gartlehner G, Hansen RA, Carey TS, Lohr KN, Gaynes BN, Randolph LC.
    Int Clin Psychopharmacol; 2005 Mar; 20(2):59-69. PubMed ID: 15729080
    [Abstract] [Full Text] [Related]

  • 11. Venlafaxine extended release versus citalopram in patients with depression unresponsive to a selective serotonin reuptake inhibitor.
    Lenox-Smith AJ, Jiang Q.
    Int Clin Psychopharmacol; 2008 May; 23(3):113-9. PubMed ID: 18408525
    [Abstract] [Full Text] [Related]

  • 12. Escitalopram versus venlafaxine XR in the treatment of depression.
    Montgomery SA, Andersen HF.
    Int Clin Psychopharmacol; 2006 Sep; 21(5):297-309. PubMed ID: 16877901
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Synergistic benefits of serotonin and noradrenaline reuptake inhibition.
    Nelson JC.
    Depress Anxiety; 1998 Sep; 7 Suppl 1():5-6. PubMed ID: 9597344
    [No Abstract] [Full Text] [Related]

  • 15. Venlafaxine, but not mirtazapine lowers retinol-binding protein 4 serum concentrations in nondiabetic depressed patients.
    Deuschle M, Angermeier T, Westphal S, Lederbogen F, Gilles M, Frankhauser P, Schilling C, Onken V, Weber-Hamann B, Kopf D.
    Psychother Psychosom; 2010 Sep; 79(2):123-5. PubMed ID: 20090399
    [No Abstract] [Full Text] [Related]

  • 16. Venlafaxine plus mirtazapine as first-line treatment for melancholia: preliminary results.
    Ruiz-Doblado S, Rueda-Villar T, Zurita-Gotor P, Sanz-Cortes S.
    J Psychopharmacol; 2010 Dec; 24(12):1837. PubMed ID: 21138931
    [No Abstract] [Full Text] [Related]

  • 17. Agranulocytosis during treatment with mianserin and venlafaxine.
    Lucht MJ, Kleinschmidt R, Maier W, Rietschel M.
    J Clin Psychopharmacol; 2000 Aug; 20(4):490-1. PubMed ID: 10917414
    [No Abstract] [Full Text] [Related]

  • 18. Are selective serotonin re-uptake inhibitors associated with an increased risk of self-harm by antidepressant overdose?
    Bateman DN, Chick J, Good AM, Kelly CA, Masterton G.
    Eur J Clin Pharmacol; 2004 May; 60(3):221-4. PubMed ID: 15083251
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. A possible case of venlafaxine-induced Stevens-Johnson syndrome.
    Weiss NT, Jones L, Chamberlain JC.
    J Clin Psychiatry; 2004 Oct; 65(10):1431-3. PubMed ID: 15491252
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 26.